OZEM Among Its Peers
End-of-day Nov 16, 2026 · 1 ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.1% | −3.2% | +5.1% | −7.3% | −10.0% | −1.4% | — | — | +22.9% |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$203 of every $1,000 in OZEM is Eli
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly & | 20.31% |
| 2 | NVO | Novo Nordisk A/S | 10.86% |
| 3 | 128940.KS | Hanmi Pharm | 6.97% |
| 4 | 4519.T | Chugai Pharmaceutical | 6.82% |
| 5 | PFE | Pfizer | 5.69% |
| 6 | KLRA | Kailera Therapeutics | 4.89% |
| 7 | 1093.HK | CSPC Pharmaceutical Group | 4.56% |
| 8 | 1276.HK | Jiangsu Hengrui Pharmaceuticals | 4.16% |
| 9 | VKTX | Viking Therapeutics | 3.94% |
| 10 | 3692.HK | Hansoh Pharmaceutical Group | 3.77% |
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly | Healthcare | 20.31% | $2,030.61 | 8,083 | $11.7M |
| 2 | NVONovo Nordisk A/S | Healthcare | 10.86% | $1,086.02 | 150K | $6.2M |
| 3 | 128940.KSHanmi Pharm | Healthcare | 6.97% | $697.22 | 12K | $4.0M |
| 4 | 4519.TChugai Pharmaceutical | Healthcare | 6.82% | $682.45 | 87K | $3.9M |
| 5 | PFEPfizer | Healthcare | 5.69% | $569.14 | 113K | $3.3M |
| 6 | KLRAKailera Therapeutics | Healthcare | 4.89% | $488.75 | 212K | $2.8M |
| 7 | 1093.HKCSPC Pharmaceutical Group | Healthcare | 4.56% | $456.05 | 2.6M | $2.6M |
| 8 | 1276.HKJiangsu Hengrui Pharmaceuticals | Healthcare | 4.16% | $416.00 | 380K | $2.4M |
| 9 | VKTXViking Therapeutics | Healthcare | 3.94% | $394.49 | 78K | $2.3M |
| 10 | 3692.HKHansoh Pharmaceutical Group | Healthcare | 3.77% | $377.22 | 494K | $2.2M |
| 11 | 1672.HKAscletis Pharma | Healthcare | 3.36% | $336.12 | 3.2M | $1.9M |
| 12 | AZNAstraZeneca | Healthcare | 3.22% | $321.84 | 10K | $1.8M |
| 13 | ZEAL.COZealand Pharma A/S | Healthcare | 3.12% | $312.20 | 50K | $1.8M |
| 14 | AMGNAmgen | Healthcare | 2.99% | $298.97 | 3,689 | $1.7M |
| 15 | GPCRStructure Therapeutics | Healthcare | 2.96% | $296.28 | 85K | $1.7M |
OZEM has no close peers in our data yet: […]
No peers with a full year of prices to rank against yet.
| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| OZEM | −0.14 | −0.22 | 23.3% | −22.4% | 0.75 | $59 |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 30, 2025 | Dec 31, 2025 | $0.41 |
| Dec 30, 2024 | Dec 31, 2024 | $0.0531 |